A disintegrin and metalloproteinase with thrombospondin motifs 5 mRNA 3′ untranslated region (ADAMTS5 mRNA 3′UTR)

The ADAMTS5 mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment of the transcript encoding A Disintegrin and Metalloproteinase with Thrombospondin Motifs 5, the primary aggrecanase involved in cartilage degradation [Glasson et al., 2005]. This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that dictate the stability and translational efficiency of the ADAMTS5 message [Miyaki et al., 2010]. In pathological conditions like osteoarthritis, the dysregulation of these regulatory interactions leads to the overexpression of ADAMTS5, resulting in the progressive loss of aggrecan from the extracellular matrix [Song et al., 2013]. Therapeutic targeting of the 3′UTR using miRNA mimics (e.g., miR-140) or antisense oligonucleotides (ASOs) aims to silence ADAMTS5 expression post-transcriptionally, thereby preserving joint integrity [Karlsen et al., 2016]. This approach offers a potential advantage over direct enzyme inhibition by providing higher specificity and avoiding the systemic side effects associated with broad-spectrum metalloproteinase inhibitors. Current research is focused on optimizing the delivery of these RNA-based therapeutics to the avascular environment of the articular cartilage [Wang et al., 2015]. As a target, the ADAMTS5 mRNA 3′UTR represents a sophisticated node for modulating the catabolic environment of the joint in degenerative diseases.

Other names

ADAMTS5 3′-UTRAggrecanase-2 mRNA 3′UTRADAM-TS 5 3′UTRADAMTS5 3-prime UTR

Binding of therapeutic agents to the 3′UTR sequence to induce mRNA degradation or block translation, thereby reducing the synthesis of the ADAMTS5 enzyme.